Cargando…

Disease progression in systemic sclerosis

Detalles Bibliográficos
Autores principales:	van Leeuwen, Nina M, Liem, Sophie I E, Maurits, Marc P, Ninaber, Maarten, Marsan, Nina Ajmone, Allaart, Cornelia F, Huizinga, Tom W J, Knevel, Rachel, de Vries-Bouwstra, Jeska K
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2021
Materias:	Letters to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7937017/ https://www.ncbi.nlm.nih.gov/pubmed/33404661 http://dx.doi.org/10.1093/rheumatology/keaa911

Ejemplares similares

New risk model is able to identify patients with a low risk of progression in systemic sclerosis
por: van Leeuwen, Nina Marijn, et al.
Publicado: (2021)

A prediction model for progressive disease in systemic sclerosis
por: Meijs, Jessica, et al.
Publicado: (2015)

Step forward in early recognition of systemic sclerosis: data from the Leiden CCISS cohort
por: Liem, Sophie I E, et al.
Publicado: (2023)

Rituximab in early systemic sclerosis
por: Boonstra, Maaike, et al.
Publicado: (2017)

Therapeutic and diagnostic outcomes of a standardised, comprehensive care pathway for patients with systemic sclerosis
por: Meijs, Jessica, et al.
Publicado: (2016)

Health-related quality of life in patients with systemic sclerosis: evolution over time and main determinants
por: van Leeuwen, Nina M, et al.
Publicado: (2021)

Pulmonary veno-occlusive disease in a patient with recently diagnosed systemic sclerosis
por: van Leeuwen, Nina M, et al.
Publicado: (2019)

Association of Anti–Topoisomerase I Antibodies of the IgM Isotype With Disease Progression in Anti–Topoisomerase I–Positive Systemic Sclerosis
por: Boonstra, Maaike, et al.
Publicado: (2020)

Evolution of Systemic Sclerosis–Associated Interstitial Lung Disease One Year After Hematopoietic Stem Cell Transplantation or Cyclophosphamide
por: Ciaffi, Jacopo, et al.
Publicado: (2022)

Progression from suspected to definite systemic sclerosis and the role of anti-topoisomerase I antibodies
por: Liem, Sophie I E, et al.
Publicado: (2023)

Illness perceptions, risk perceptions and worries in patients with early systemic sclerosis: A focus group study
por: van Leeuwen, Nina M., et al.
Publicado: (2020)

Contribution of Sex and Autoantibodies to Microangiopathy Assessed by Nailfold Videocapillaroscopy in Systemic Sclerosis: A Systematic Review of the Literature
por: van Leeuwen, Nina M., et al.
Publicado: (2021)

Physical activity in patients with systemic sclerosis
por: Liem, S. I. E., et al.
Publicado: (2017)

Gastrointestinal symptom severity and progression in systemic sclerosis
por: van Leeuwen, Nina M, et al.
Publicado: (2022)

The effect of silver fibre gloves on Raynaud’s phenomenon in patients with systemic sclerosis: a double-blind randomized crossover trial
por: Liem, Sophie I E, et al.
Publicado: (2022)

Anti-topoisomerase, but not anti-centromere B cell responses in systemic sclerosis display active, Ig-secreting cells associated with lung fibrosis
por: Wortel, Corrie M, et al.
Publicado: (2023)

Sex-specific difference in cardiac function in patients with systemic sclerosis: association with cardiovascular outcomes
por: Gegenava, Tea, et al.
Publicado: (2023)

Evaluation of left cardiac chamber function with cardiac magnetic resonance and association with outcome in patients with systemic sclerosis
por: Butcher, Steele C, et al.
Publicado: (2022)

Anticentromere Antibody Levels and Isotypes and the Development of Systemic Sclerosis
por: van Leeuwen, Nina M., et al.
Publicado: (2021)

The long-term course of the Health Assessment Questionnaire in patients with systemic sclerosis
por: Liem, Sophie IE, et al.
Publicado: (2023)

The effect and safety of exercise therapy in patients with systemic sclerosis: a systematic review
por: Liem, Sophie I E, et al.
Publicado: (2019)

Anti-carbamylated protein antibodies in systemic sclerosis
por: Liem, Sophie I. E., et al.
Publicado: (2023)

Whole body insulin sensitivity is increased in systemic sclerosis
por: Ciaffi, Jacopo, et al.
Publicado: (2023)

Reply from authors: Many roads lead to Rome
por: Wijngaarden, Aniek L., et al.
Publicado: (2021)

Accelerated hand bone mineral density loss is associated with progressive joint damage in hands and feet in recent-onset rheumatoid arthritis
por: Güler-Yüksel, Melek, et al.
Publicado: (2010)

Feasibility of tailored treatment based on risk stratification in patients with early rheumatoid arthritis
por: Markusse, Iris M, et al.
Publicado: (2014)

Response to ‘Feasibility of tailored treatment based on risk stratification in patients with early rheumatoid arthritis’ – authors’ reply
por: Markusse, Iris M., et al.
Publicado: (2015)

The Prognostic Value of Right Atrial and Right Ventricular Functional Parameters in Systemic Sclerosis
por: Vos, Jacqueline L., et al.
Publicado: (2022)

Interpreting big-data analysis of retrospective observational data
por: Huizinga, Tom W J, et al.
Publicado: (2020)

OTUD6B-AS1 Might Be a Novel Regulator of Apoptosis in Systemic Sclerosis
por: Takata, Miki, et al.
Publicado: (2019)

The year in cardiovascular medicine 2022: the top 10 papers in cardiovascular imaging
por: Bucciarelli-Ducci, Chiara, et al.
Publicado: (2023)

Requirements for systemic sclerosis expert centres in the Netherlands: A Delphi consensus study
por: Spierings, Julia, et al.
Publicado: (2020)

Systemic sclerosis in the time of COVID-19
por: Hoffmann-Vold, Anna-Maria, et al.
Publicado: (2022)

Characterizing mitral regurgitation in a contemporary population: prognostic implications
por: Delgado, Victoria, et al.
Publicado: (2019)

Exploring the effects of a combined exercise programme on pain and fatigue outcomes in people with systemic sclerosis: study protocol for a large European multi-centre randomised controlled trial
por: Mitropoulos, Alexandros, et al.
Publicado: (2022)

Identification of regulators of the myofibroblast phenotype of primary dermal fibroblasts from early diffuse systemic sclerosis patients
por: Chadli, Loubna, et al.
Publicado: (2019)

Malignant Arrhythmic Mitral Valve Prolapse: A Continuum of Clinical Challenges from Diagnosis to Risk Stratification and Patient Management
por: Yedidya, Idit, et al.
Publicado: (2020)

An evaluation of molecular and clinical remission in rheumatoid arthritis by assessing radiographic progression
por: van der Helm-van Mil, Annette H. M., et al.
Publicado: (2013)

Anti‐C1q autoantibodies may not serve as an adequate biomarker for lung manifestations in systemic sclerosis: a single‐centre, cross‐sectional study
por: Dijkstra, D.J., et al.
Publicado: (2021)

Pacemaker lead-induced tricuspid regurgitation: consider leaflet remodeling
por: Fortuni, Federico, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_sgdfujrdjprk789m2t7rac137s